Gian Life Care Share Price
4.82-0.04 (-0.82%)
-66.06% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | -25% | -49% |
| - | - | - | -101% |
| - | -26% | -43% | -66% |
| 16% | 16% | 10% | 0% |
Peer Comparison
Symbol
APOLLOHOSP-A
MAXHEALTH-A
FORTIS-A
ASTERDM-A
NH-A
MEDANTA-A
LALPATHLAB-A
KIMS-A
AGARWALEYE-A
VIJAYA-A
GIANLIFE-Z
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 8,670 | ₹126300 Cr | 60.45 | 40.39 | 207.67 | ₹1942 Cr |
| 985 | ₹96763 Cr | 66.42 | 3.31 | 19.84 | ₹1442 Cr |
| 910 | ₹68901 Cr | 65.75 | 3.53 | 20.1 | ₹1042 Cr |
| 785.15 | ₹68592 Cr | 215.24 | 0.31 | 6.76 | ₹464 Cr |
| 1,861 | ₹38439 Cr | 47.1 | 10.14 | 65.36 | ₹806 Cr |
| 1,478 | ₹38149 Cr | 68.59 | 5.91 | 29.85 | ₹556 Cr |
| 1,891.3 | ₹32259 Cr | 59.53 | 10.11 | 42.51 | ₹505 Cr |
| 761.95 | ₹32231 Cr | 157.77 | 1.04 | 12.74 | ₹241 Cr |
| 515.35 | ₹16249 Cr | 109.52 | 1.43 | 13.88 | ₹133 Cr |
| 1,490 | ₹15511 Cr | 82.73 | 5.16 | 27.53 | ₹173 Cr |
| 4.82 | ₹5 Cr | — | 0.1 | -0.34 | -₹4 L |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹1 Cr | ₹66 L | ₹87 L | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹5 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹6 Cr |
| ₹9 L | ₹9 L | ₹16 L | -₹25 L | ₹16 L | ₹17 L | ₹19 L | ₹18 L | ₹19 L | ₹15 L | ₹15 L | ₹18 L | ₹17 L | ₹34 L | ₹17 L | ₹29 L | ₹7 L |
| ₹1 Cr | ₹75 L | ₹1 Cr | ₹87 L | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹5 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹5 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹6 Cr |
| ₹99 L | ₹1 Cr | ₹85 L | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr |
| ₹34 L | -₹32 L | ₹29 L | -₹25 L | ₹63 L | ₹39 L | ₹41 L | ₹3 Cr | ₹2 Cr | ₹48 L | ₹65 L | -₹59 L | ₹2 Cr | ₹76 L | ₹14 L | -₹1 Cr | ₹4 Cr |
| ₹15 L | ₹12 L | ₹9 L | ₹13 L | ₹12 L | ₹13 L | ₹14 L | ₹10 L | ₹14 L | ₹11 L | ₹12 L | ₹11 L | ₹12 L | ₹10 L | ₹10 L | ₹21 L | ₹5 L |
| ₹8 L | -₹55 L | ₹8 L | -₹65 L | ₹39 L | ₹14 L | ₹15 L | ₹3 Cr | ₹2 Cr | ₹24 L | ₹40 L | -₹82 L | ₹2 Cr | ₹55 L | -₹8 L | -₹2 Cr | ₹4 Cr |
| ₹10 L | -₹51 L | ₹5 L | -₹60 L | ₹35 L | ₹12 L | ₹9 L | ₹2 Cr | ₹2 Cr | ₹20 L | ₹26 L | -₹95 L | ₹2 Cr | ₹46 L | -₹8 L | -₹1 Cr | ₹3 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| — | — | — | — |
| ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
| ₹9 Cr | ₹9 Cr | ₹5 Cr | ₹4 Cr |
| ₹9 Cr | ₹9 Cr | ₹5 Cr | ₹4 Cr |
| ₹19 Cr | ₹19 Cr | ₹15 Cr | ₹14 Cr |
| ₹2,000 | ₹2,000 | ₹2,000 | ₹0 |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| ₹1 Cr | ₹0 | ₹0 | ₹0 |
| ₹9 L | ₹15 L | ₹16 L | ₹18 L |
| ₹76 L | ₹73 L | ₹41 L | ₹8 L |
| ₹16 L | ₹14 L | ₹12 L | ₹0 |
| ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr |
| — | — | — | — |
| ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr |
| ₹3 Cr | ₹1 Cr | ₹3 Cr | ₹4 Cr |
| ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹0 |
| ₹4 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr |
| ₹13 Cr | ₹10 Cr | ₹11 Cr | ₹7 Cr |
| ₹36 Cr | ₹33 Cr | ₹28 Cr | ₹23 Cr |
| ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹2 Cr |
| — | — | — | — |
| ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹4 Cr |
| ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹89 L |
| ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr |
| ₹14 L | ₹14 L | ₹14 L | ₹12 L |
| ₹13 Cr | ₹14 Cr | ₹12 Cr | ₹9 Cr |
| ₹0 | ₹32 L | ₹30 L | ₹29 L |
| ₹18 Cr | ₹19 Cr | ₹17 Cr | ₹13 Cr |
| — | — | — | — |
| ₹62 L | ₹88 L | ₹88 L | ₹1 Cr |
| ₹6 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr |
| ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr |
| ₹5 Cr | ₹2 Cr | ₹2 Cr | ₹34 L |
| ₹0 | ₹0 | ₹2 L | ₹2 Cr |
| ₹18 Cr | ₹13 Cr | ₹11 Cr | ₹10 Cr |
| ₹6 Cr | ₹3 Cr | ₹72 L | ₹4 Cr |
| ₹36 Cr | ₹33 Cr | ₹28 Cr | ₹23 Cr |
| ₹19 | ₹19 | ₹15 | ₹14 |
| ₹19 | ₹19 | ₹15 | ₹14 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| ₹4 L | ₹6 Cr | ₹2 Cr | ₹6 Cr |
| ₹87 L | ₹33 L | ₹26 L | ₹2 Cr |
| -₹62 L | -₹5 Cr | ₹40 L | -₹1 Cr |
| ₹29 L | ₹71 L | ₹2 Cr | ₹6 Cr |
| ₹27 L | ₹70 L | ₹2 Cr | ₹6 Cr |
| ₹25 L | -₹32 L | -₹94 L | -₹4 Cr |
| ₹45 L | -₹16 L | -₹37 L | ₹67 L |
| ₹97 L | ₹22 L | ₹91 L | ₹2 Cr |
| ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹3 Cr |
| ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found